245107-59-9Relevant academic research and scientific papers
Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1)
Chien, Huan-Chieh,Colas, Claire,Finke, Karissa,Springer, Seth,Stoner, Laura,Zur, Arik A.,Venteicher, Brooklynn,Campbell, Jerome,Hall, Colton,Flint, Andrew,Augustyn, Evan,Hernandez, Christopher,Heeren, Nathan,Hansen, Logan,Anthony, Abby,Bauer, Justine,Fotiadis, Dimitrios,Schlessinger, Avner,Giacomini, Kathleen M.,Thomas, Allen A.
, p. 7358 - 7373 (2018/08/06)
The L-type amino acid transporter 1 (LAT1, SLC7A5) transports essential amino acids across the blood-brain barrier (BBB) and into cancer cells. To utilize LAT1 for drug delivery, potent amino acid promoieties are desired, as prodrugs must compete with millimolar concentrations of endogenous amino acids. To better understand ligand-transporter interactions that could improve potency, we developed structural LAT1 models to guide the design of substituted analogues of phenylalanine and histidine. Furthermore, we evaluated the structure-activity relationship (SAR) for both enantiomers of naturally occurring LAT1 substrates. Analogues were tested in cis-inhibition and trans-stimulation cell assays to determine potency and uptake rate. Surprisingly, LAT1 can transport amino acid-like substrates with wide-ranging polarities including those containing ionizable substituents. Additionally, the rate of LAT1 transport was generally nonstereoselective even though enantiomers likely exhibit different binding modes. Our findings have broad implications to the development of new treatments for brain disorders and cancer.
Synthesis of (R)-α-benzylmethionine: a novel rearrangement during alkylation of the Seebach (R)-methionine oxazolidinone
Procopiou, Panayiotis A.,Ahmed, Mahmood,Jeulin, Severine,Perciaccante, Rossana
, p. 2853 - 2858 (2007/10/03)
Alkylation of the enolate of the Seebach (R)-methionine oxazolidinone with benzyl bromide gave the expected benzylated product in low yield. The major product was a novel amine arising from oxazolidinone cleavage, decarboxylation, alkylation and finally hydrolysis. The rearrangement could be suppressed by using a more reactive electrophile or by using the N-Cbz instead of the N-benzoyl protecting group, and the required (R)-α-benzyl-methionine was obtained in 78% yield and in an enantiomeric ratio of 90 : 10.
Synthesis of a conformationally constrained threonine-valine dipeptide mimetic: Design of a potential inhibitor of plasminogen activator inhibitor-1
Guzzo, Peter R,Trova, Michael P,Inghardt, Tord,Linschoten, Marcel
, p. 41 - 43 (2007/10/03)
The stereoselective synthesis of a conformationally restricted threonine-valine dipeptide mimetic and its incorporation into a tetrapeptide is described.
Design and synthesis of diaminopyrrolidinone inhibitors of human osteoclast cathepsin K
Duffy, Kevin J.,Ridgers, Lance H.,Desjarlais, Renee L.,Tomaszek, Thaddeus A.,Bossard, Mary J.,Thompson, Scott K.,Keenan, Richard M.,Veber, Daniel F.
, p. 1907 - 1910 (2007/10/03)
The structure-based design and synthesis of lactam-constrained azapeptide inhibitors of human cathepsin K are described. Enhanced stability to proteolytic cleavage over acyclic analogues is discussed.
